Sequent Scientific Share Price

  • 122.323.18 (2.67%)
  • Volume: 14,75,134
  • Closed
  • Last Updated On: 11 Jun, 2024, 03:57 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Sequent Scientific Shar...

  • 122.323.18 (2.67%)
  • Volume: 14,75,134
Advertisment

Sequent Scientific share price insights

View All

  • Sales de-grew by 3.27%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)

  • Stock gave a 3 year return of -56.4% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

  • Company has spent 3.51% of its operating revenues towards interest expenses and 18.29% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

  • Stock generated -56.4% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

  • Sequent Scientific Ltd. share price moved up by 2.67% from its previous close of Rs 119.14. Sequent Scientific Ltd. stock last traded price is 122.32

    Share PriceValue
    Today/Current/Last122.32
    Previous Day119.14119.15

InsightsSequent Scientific

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		-85.06
    EPS - TTM
    (₹)    		-1.44
    MCap
    (₹ Cr.)    		2,971.75
    Sectoral MCap Rank
    		51
    PB Ratio
    (x)    		4.17
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		2.00
    Beta

    Beta

    1 Month1.03
    3 Months0.93
    6 Months1.16
    1 Year1.39
    3 Years1.45

    		1.03
    VWAP
    (₹)    		121.47
    52W H/L
    (₹)
    155.50 / 74.60

    Sequent Scientific Share Price Returns

    1 Day2.67%
    1 Week23.68%
    1 Month3.97%
    3 Months-1.55%
    1 Year60.52%
    3 Years-55.01%
    5 Years76.51%

    ET Stock ScreenersTop Score Companies

    Check whether Sequent Scientific belongs to analysts' top-rated companies list?

    View Stock Screeners

    Sequent Scientific News & Analysis

    View all Sequent Scientific Share News & Announcements

    Sequent Scientific Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Sequent Scientific Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Sequent Scientific Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Topline Contraction

        Sales de-grew by 3.27%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent 3.51% of its operating revenues towards interest expenses and 18.29% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income365.20333.88347.62334.00368.41
      Total Income Growth (%)9.38-3.954.08-9.34-2.58
      Total Expenses350.12319.81338.13379.20446.34
      Total Expenses Growth (%)9.48-5.42-10.83-15.0417.88
      EBIT15.0814.079.49-45.20-77.93
      EBIT Growth (%)7.1448.34---
      Profit after Tax (PAT)-0.918.27-8.38-34.85-93.57
      PAT Growth (%)-111.02----
      EBIT Margin (%)4.134.212.73-13.53-21.15
      Net Profit Margin (%)-0.252.48-2.41-10.43-25.40
      Basic EPS (₹)-0.040.33-0.34-1.40-3.77
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income49.7555.6558.9950.1254.61
      Total Income Growth (%)-10.61-5.6617.69-8.22-15.50
      Total Expenses44.6248.4159.1758.1754.97
      Total Expenses Growth (%)-7.83-18.181.725.82-19.04
      EBIT5.137.24-0.19-8.05-0.36
      EBIT Growth (%)-29.16----
      Profit after Tax (PAT)3.764.58-0.92-6.80-1.65
      PAT Growth (%)-17.84----
      EBIT Margin (%)10.3013.00-0.32-16.06-0.66
      Net Profit Margin (%)7.568.23-1.56-13.57-3.01
      Basic EPS (₹)0.150.18-0.04-0.27-0.07
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue1,380.691,427.301,423.661,369.981,189.33
      Total Revenue Growth (%)-3.270.263.9215.1913.49
      Total Expenses1,417.941,500.161,370.281,224.531,095.26
      Total Expenses Growth (%)-5.489.4811.9011.8010.73
      Profit after Tax (PAT)-35.87-121.1641.2595.4469.91
      PAT Growth (%)--393.71-56.7836.5343.66
      Operating Profit Margin (%)0.79-2.624.8912.4711.00
      Net Profit Margin (%)-2.61-8.522.917.005.92
      Basic EPS (₹)-1.44-4.881.673.872.87
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue214.50250.93247.27285.42241.89
      Total Revenue Growth (%)-14.521.48-13.3718.0034.22
      Total Expenses208.48260.67231.58241.98219.08
      Total Expenses Growth (%)-20.0212.56-4.3010.4525.90
      Profit after Tax (PAT)0.62-6.0814.8032.1121.34
      PAT Growth (%)--141.08-53.9250.48181.32
      Operating Profit Margin (%)6.15-3.247.8717.3712.24
      Net Profit Margin (%)0.36-2.736.7312.099.38
      Basic EPS (₹)0.03-0.240.601.300.88

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets1,540.381,529.121,441.501,392.561,518.30
      Total Assets Growth (%)0.746.083.51-8.289.40
      Total Liabilities827.43779.93701.08616.24730.81
      Total Liabilities Growth (%)6.0911.2513.77-15.6814.02
      Total Equity712.96749.19740.41776.32787.50
      Total Equity Growth (%)-4.841.19-4.62-1.425.43
      Current Ratio (x)1.311.501.541.551.50
      Total Debt to Equity (x)0.690.570.460.270.38
      Contingent Liabilities0.00184.31223.526.262.59
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets1,187.601,122.771,124.231,102.12997.37
      Total Assets Growth (%)5.77-0.132.0110.50-2.11
      Total Liabilities100.3764.4183.1472.61111.15
      Total Liabilities Growth (%)55.83-22.5314.50-34.679.94
      Total Equity1,087.231,058.361,041.091,029.51886.22
      Total Equity Growth (%)2.731.661.1216.17-3.44
      Current Ratio (x)1.071.381.811.691.20
      Total Debt to Equity (x)0.040.020.020.010.03
      Contingent Liabilities0.00266.31247.440.990.64

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 5.92 cr for investing activities which is an YoY decrease of 90.89%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities30.5916.8130.60114.75115.33
      Net Cash used in Investing Activities-5.92-64.96-95.579.65-72.27
      Net Cash flow from Financing Activities-1.4432.2367.26-138.75-42.75
      Net Cash Flow23.24-15.923.75-14.350.31
      Closing Cash & Cash Equivalent64.8141.5757.5053.7468.10
      Closing Cash & Cash Equivalent Growth (%)55.89-27.696.98-21.080.45
      Total Debt/ CFO (x)14.7523.6710.291.712.47
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities-26.9437.759.362.3430.20
      Net Cash used in Investing Activities5.47-50.70-4.25170.00-10.39
      Net Cash flow from Financing Activities22.320.247.25-174.78-18.01
      Net Cash Flow0.84-12.7112.36-2.441.81
      Closing Cash & Cash Equivalent0.930.0812.800.442.87
      Closing Cash & Cash Equivalent Growth (%)1,015.66-99.352,841.61-84.86169.51
      Total Debt/ CFO (x)-1.720.511.662.230.98

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)-5.46-17.336.0313.119.41
      Return on Capital Employed (%)1.18-3.727.4418.2212.37
      Return on Assets (%)-2.32-7.922.866.854.60
      Interest Coverage Ratio (x)1.510.527.626.973.63
      Asset Turnover Ratio (x)0.890.170.1797.7777.66
      Price to Earnings (x)-80.65-14.9580.6562.8927.62
      Price to Book (x)4.382.594.868.222.60
      EV/EBITDA (x)45.79120.8630.1628.0012.10
      EBITDA Margin (%)5.281.298.5116.1815.29
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)0.05-0.571.433.112.40
      Return on Capital Employed (%)0.95-0.681.654.473.07
      Return on Assets (%)0.05-0.541.312.912.13
      Interest Coverage Ratio (x)4.430.7516.7017.215.53
      Asset Turnover Ratio (x)0.150.200.2024.0822.79
      Price to Earnings (x)5,000.00-303.03227.27188.6890.91
      Price to Book (x)2.651.713.225.812.18
      EV/EBITDA (x)151.24972.14123.67108.3653.15
      EBITDA Margin (%)11.460.8412.2420.8116.18

    Financial InsightsSequent Scientific

    • Income (P&L)
    • Cash Flow

      • Topline Contraction

        Sales de-grew by 3.27%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent 3.51% of its operating revenues towards interest expenses and 18.29% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 5.92 cr for investing activities which is an YoY decrease of 90.89%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Sequent Scientific Peer Comparison

    • Sequent Scientific Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -56.4% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated -56.4% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of -56.4% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated -56.4% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Sequent Scientific-82.854.17-5.461.18-2.320.260.79-2.16-1.441.310.6914.75
          Gufic BioSci43.707.0716.1718.187.8817.8716.2410.678.741.610.60-42.50
          Hikal Ltd52.773.095.868.772.791.168.513.905.641.280.694.36
          Indoco Remedies30.242.688.8710.594.5913.518.935.3310.531.560.614.29
          Supriya Lifescience24.803.6214.6019.8712.9213.4629.4120.8814.805.170.000.00
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Innova Captab
          • Dishman Carbogen
          • RPG Life Sci
          • Morepen Labs
          • IOL Chemicals

          Choose from Stocks

            See All Parameters

          Peers InsightsSequent Scientific

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of -56.4% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated -56.4% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Sequent Scientific Shareholding Pattern

          • QOQ Change

          • Total Shareholdings

          • Loading...
            Showing Sequent Scientific Shareholding as on 31 Mar 2024
            Category31 Mar 202431 Dec 202330 Sep 202330 Jun 2023
            Promoters52.7952.7952.7952.79
            Pledge0.000.000.000.00
            FII6.166.116.036.27
            DII7.597.223.232.92
            Mutual Funds5.165.021.030.25
            Others33.4533.8737.9538.01
          • Showing Shareholding as on 31 Mar 2024
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters13,16,80,10352.79 %0.00
            Pledge00.00 %0.00
            FII1,53,72,2376.16 %0.04
            DII1,89,34,8747.59 %0.36
            MF1,28,61,9515.16 %0.14
            Others8,34,46,28133.45 %-0.42

          MF Ownership

          MF Ownership as on 30 April 2024

          View all Mutual Fund Schemes

          Top Searches:

          Sequent Scientific News Sequent Scientific Quarterly Results Sequent Scientific Dividend Sequent Scientific Q1 ResultsSequent Scientific Q2 ResultsSequent Scientific Q3 ResultsSequent Scientific Q4 Results

          Corporate Actions

          • Sequent Scientific Board Meeting/AGM

          • Sequent Scientific Dividends

          • Others
          • Meeting DateAnnounced onPurposeDetails
            May 15, 2024May 08, 2024Board MeetingAudited Results & Final Dividend
            Mar 09, 2024Feb 07, 2024POM-
            Feb 13, 2024Feb 06, 2024Board MeetingQuarterly Results
            Nov 06, 2023Oct 30, 2023Board MeetingQuarterly Results
            Oct 24, 2023Sep 21, 2023POM-
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Final25%0.5Sep 08, 2021Jul 01, 2021
            Final10%0.2Aug 21, 2019May 14, 2019
            Interim10%0.2Nov 20, 2017Nov 09, 2017
            Final 15%1.5Sep 16, 2011May 30, 2011
            Final 20%2.0Sep 23, 2010May 31, 2010
          • All TypesEx-DateRecord DateAnnounced onDetails
            SplitsFeb 25, 2016Feb 26, 2016Oct 29, 2015Split: Old FV10.0| New FV:2.0

          About Sequent Scientific

          Sequent Scientific Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 2,971.75 Crore) operating in Pharmaceuticals sector. Sequent Scientific Ltd. key Products/Revenue Segments include Bulk Drugs, Other Operating Revenue, Chemicals, Duty Drawback, Scrap for the year ending 31-Mar-2023. Show More

          • Executives

          • Auditors

          • KK

            Kamal K Sharma

            Chairman & Ind.Director
            RN

            Rajaram Narayanan

            Managing Director & CEO
            SN

            Sharat Narasapur

            Joint Managing Director
            FK

            Fabian Kausche

            Non Executive Director
            Show More
          • S R B C & Co. LLP

          Industry

          Pharma - Indian

          Key Indices Listed on

          S&P BSE SmallCap, S&P BSE Healthcare, S&P BSE AllCap, + 4 more

          Address

          301, 3rd Floor, �Dosti Pinnacle�,Plot No. E7, Road No.22,Wagle Industrial Estate,Mumbai, Maharashtra - 400604

          Contact

          [email protected]

          http://www.sequent.in

          More Details

          FAQs about Sequent Scientific share

          • 1. What is Sequent Scientific share price and what are the returns for Sequent Scientific share?
            As on 11 Jun, 2024, 03:57 PM IST Sequent Scientific share price was up by 2.67% basis the previous closing price of Rs 120.35. Sequent Scientific share price was Rs 122.32. Return Performance of Sequent Scientific Shares:
            • 1 Week: Sequent Scientific share price moved up by 23.68%
            • 1 Month: Sequent Scientific share price moved up by 3.97%
            • 3 Month: Sequent Scientific share price moved down by 1.55%
            • 6 Month: Sequent Scientific share price moved up by 1.98%
          • 2. What is the CAGR of Sequent Scientific?
            The CAGR of Sequent Scientific is 0.15.
          • 3. Which are the key peers to Sequent Scientific?
            Top 10 Peers for Sequent Scientific are Indoco Remedies Ltd., Supriya Lifescience Ltd., Innova Captab Ltd., Gufic BioSciences Ltd., Dishman Carbogen Amcis Ltd., Morepen Laboratories Ltd., RPG Life Sciences Ltd., Hikal Ltd., Unichem Laboratories Ltd. and IOL Chemicals and Pharmaceuticals Ltd.
          • 4. Who's the chairman of Sequent Scientific?
            Kamal K Sharma is the Chairman & Ind.Director of Sequent Scientific
          • 5. What are the returns for Sequent Scientific share?
            Return Performance of Sequent Scientific Shares:
            • 1 Week: Sequent Scientific share price moved up by 23.68%
            • 1 Month: Sequent Scientific share price moved up by 3.97%
            • 3 Month: Sequent Scientific share price moved down by 1.55%
            • 6 Month: Sequent Scientific share price moved up by 1.98%
          • 6. What is the PE & PB ratio of Sequent Scientific?
            The PE ratio of Sequent Scientific stands at -82.85, while the PB ratio is 4.17.
          • 7. What dividend is Sequent Scientific giving?
            Sequent Scientific Ltd. announced an equity dividend of 25% on a face value of 2.0 amounting to Rs 0.5 per share on 01 Jul 2021. The ex dividend date was 08 Sep 2021.
          • 8. What are the Sequent Scientific quarterly results?
            Total Revenue and Earning for Sequent Scientific for the year ending 2024-03-31 was Rs 1380.69 Cr and Rs -35.87 Cr on Consolidated basis. Last Quarter 2024-03-31, Sequent Scientific reported an income of Rs 365.20 Cr and loss of Rs -0.91 Cr.
          • 9. What is 52 week high/low of Sequent Scientific share price?
            In last 52 weeks Sequent Scientific share had a high price of Rs 155.50 and low price of Rs 74.60
          • 10. What's the market capitalization of Sequent Scientific?
            Sequent Scientific share has a market capitalization of Rs 2,971.75 Cr. Within Pharmaceuticals sector, it's market cap rank is 51.
          • 11. Who are the key owners of Sequent Scientific stock?
            Promoter,DII and FII owns 52.79, 7.22 and 6.11 shares of Sequent Scientific as on 31 Mar 2024
            • There is no change in promoter holding from 31 Dec 2023 to 31 Mar 2024
            • Domestic Institutional Investors holding has gone up from 7.22 (31 Dec 2023) to 7.59 (31 Mar 2024)
            • Foreign Institutional Investors holding has gone up from 6.11 (31 Dec 2023) to 6.16 (31 Mar 2024)
            • Other investor holding have gone down from 33.87 (31 Dec 2023) to 33.45 (31 Mar 2024)
          • 12. How can I quickly analyze Sequent Scientific stock?
            Key Metrics for Sequent Scientific are:
            • PE Ratio of Sequent Scientific is -85.06
            • Price/Sales ratio of Sequent Scientific is 2.10
            • Price to Book ratio of Sequent Scientific is 4.17
          • 13. Who is the CEO of Sequent Scientific?
            Rajaram Narayanan is the Managing Director & CEO of Sequent Scientific

          Trending in Markets

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Sequent Scientific Share Price
          The Economic Times